MediWound Ltd.(MDWD)

Sector:

Healthcare

Description:

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.

Current Price

$8.91

RSI

21.35

Market Capitalization:

59.7M

Beta:

0.961

Volume:

28,029

Analyst Target Price:

$ 6.33

Economiic Fair Price:


November 15, 2022
September 30, 2022
Q3
N/A
N/A
N/A
N/A
N/A
952000
-0.517
-73.80 %
0.718
-4.227

-12.60 %
-66.51 %
-205.96 %
-4.19 %
-32.05 %
-359.84 %

$ 23.8M
9.19 %
$ 21.8M
-31.54 %
$ 31.8M
834.70 %
$ 3.4M
36.26 %
$ 2.5M
60.21 %
$ 1.6M

$ -9.4M
-20.30 %
$ -7.8M
-204.28 %
$ 7.5M
159.09 %
$ -12.7M
27.62 %
$ -17.5M
-2.24 %
$ -17.1M

$ -13.5M
-45.80 %
$ -9.3M
-548.98 %
$ 2.1M
136.47 %
$ -5.7M
61.02 %
$ -14.5M
23.04 %
$ -18.9M

News

Press Releases

Notable Dates